A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Seagen Inc.
Seagen Inc.
Affimed GmbH
University of Nebraska
Therapeutic Advances in Childhood Leukemia Consortium
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Eisai Inc.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Yale University
M.D. Anderson Cancer Center